Bromide

Bromide

SCHEMBL635580

CCCCCCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[Br-]

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.56
TRAP1 Q12931 2/20 0.46
CHRNA7 P36544 7/20 0.45
ALDH1A1 P00352 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
TSHR P16473 1/20 0.44
CYP2C19 P33261 1/20 0.44
DNM1 Q05193 2/20 0.43
CSNK1E P49674 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL286882 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2
Bromide SCHEMBL2446607 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2
Bromide SCHEMBL678415 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2
Bromide SCHEMBL362235 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2
Bromide SCHEMBL1866839 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2
Bromide SCHEMBL7759526 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2
Bromide SCHEMBL8775234 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2
Bromide SCHEMBL164301 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2
Bromide SCHEMBL2979400 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2
Bromide SCHEMBL1963378 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115888674-A Uranium adsorption material and preparation method and application thereof 核工业北京化工冶金研究院 2023-04-04 CN claimed
CN-114318853-A Modified antibacterial fiber 安徽润齐新材料科技有限公司 2022-04-12 CN claimed
CN-113278086-A Antibacterial material of quaternary phosphonium salt modified locust bean gum 广州市尚信净化工程有限公司 2021-08-20 CN claimed
CN-109734599-A The synthetic method of one kind (Z/E) -8- dodecylene -1- alcohol acetate compound 山东省农药科学研究院 2019-05-10 CN claimed
US-6316575-B1 MELT TRANSESTERIFICATION OF DIOL COMPOUND AND CARBOANTE COMPOUND USING CATALYST COMPRISING A PHOSPHORUS-CONTAINING BASIC COMPOUND QUATERNARY PHOSPHONIUM SALT TO FORM POLYCARBONATE IDEMITSU KOSAN CO., LTD. (JP) 2001-11-13 US claimed
EP-0401589-B1 Method of producing imide bond-containing resins DAI ICHI KOGYO SEIYAKU CO LTD (JP) 1994-10-26 EP claimed
US-5086114-A Reacting anhydride-containing copolymer with diisocyanate and halogenated phthalic anhydride in the prense of quaternary phosphonium compound DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) 1992-02-04 US claimed
WO-2024261685-A1 HARDENING COMPOSITION BASED ON RENEWABLE RAW MATERIALS ECOPOX GMBH & CO. KG (DE) 2024-12-26 WO disclosed
EP-4480983-A1 CURING COMPOSITION BASED ON RENEWABLE RAW MATERIALS ECOPOX GmbH & Co. KG (DE) 2024-12-25 EP disclosed
CN-115888674-B Uranium adsorption material, preparation method and application thereof 核工业北京化工冶金研究院 2024-12-20 CN disclosed
US-20240300987-A1 TRAP1 INHIBITOR AND USE THEREOF UNIST (ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY) (KR) 2024-09-12 US disclosed
WO-2024146848-A1 CURABLE MATERIALS BASED ON CYCLIC THIOETHER COMPOUNDS, AND USES THEREOF DELO INDUSTRIE KLEBSTOFFE GMBH & CO. KGAA (DE) 2024-07-11 WO disclosed
EP-4357351-A1 TRAP1 INHIBITOR AND USE THEREOF Smartin Bio Inc. (KR) 2024-04-24 EP disclosed
US-4391827-A 3-(2-Hydroxy-4-(substituted)phenyl)-cycloalkanone and cycloalkanol analgesic agents and intermediates therefor PFIZER INC. (US) 1983-07-05 US disclosed
US-4376786-A Combating arthropods with 4-fluoro-3-phenoxy-benzyl 3-alken-1-yl-2,2-dimethyl-cyclopropanecarboxylates BAYER AKTIENGESELLSCHAFT (DE) 1983-03-15 US disclosed
EP-0061053-A1 3-Alkene-1-yl-2,2-dimethyl-cyclopropanecarboxylic acid 4-fluoro-3-phenoxy-benzylesters, process for their preparation and their use in pesticides BAYER AG (DE) 1982-09-29 EP disclosed
US-4306097-A 3-[2-Hydroxy-4-(substituted)phenyl]-cycloalkanol analgesic agents PFIZER INC. (US) 1981-12-15 US disclosed
EP-0003294-B1 USE OF AROMATIC POLYESTERS FOR OPTICAL LENSES BAYER AG (DE) 1980-10-15 EP disclosed
US-4225698-A HIGH QUALITY LENSES FOR STILL AND MOVIE CAMERAS BAYER AKTIENGESELLSCHAFT (DE) 1980-09-30 US disclosed
EP-0003294-A1 Use of aromatic polyesters for optical lenses BAYER AG (DE) 1979-08-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240300987-A1 TRAP1 INHIBITOR AND USE THEREOF TRAP1, PPP1R7, PPP1R15A HIF1A 4001/4885TRAP1 1/4885CHRNA7 4130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.